Cargando…
Colon cancer cell treatment with rose bengal generates a protective immune response via immunogenic cell death
Immunotherapeutic approaches to manage patients with advanced gastrointestinal malignancies are desired; however, mechanisms to incite tumor-specific immune responses remain to be elucidated. Rose bengal (RB) is toxic at low concentrations to malignant cells and may induce damage-associated molecula...
Autores principales: | Qin, Jianzhong, Kunda, Nicholas, Qiao, Guilin, Calata, Jed F, Pardiwala, Krunal, Prabhakar, Bellur S, Maker, Ajay V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386459/ https://www.ncbi.nlm.nih.gov/pubmed/28151483 http://dx.doi.org/10.1038/cddis.2016.473 |
Ejemplares similares
-
The Potential of Intralesional Rose Bengal to Stimulate T-Cell Mediated Anti-Tumor Responses
por: Maker, Ajay V, et al.
Publicado: (2015) -
Targeting the metabolic pathway of human colon cancer overcomes resistance to TRAIL-induced apoptosis
por: Carr, Ryan M, et al.
Publicado: (2016) -
LIGHT enhanced bispecific antibody armed T-cells to treat immunotherapy resistant colon cancer
por: Qiao, Guilin, et al.
Publicado: (2022) -
Timing the multiple cell death pathways initiated by Rose Bengal acetate photodynamic therapy
por: Panzarini, E, et al.
Publicado: (2011) -
Identification of a Novel OX40L(+) Dendritic Cell Subset That Selectively Expands Regulatory T cells
por: Marinelarena, Alejandra, et al.
Publicado: (2018)